Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s. It is primarily characterized by motor symptoms such as tremors, rigidity, and slowed movement, and in later stages, it often progresses to include cognitive decline and dementia.
The root cause of Parkinson’s is the progressive degeneration of dopamine-producing neurons in the brain. As dopamine levels fall, motor control becomes increasingly impaired. While current medications aim to increase dopamine levels and manage symptoms, they do not address the underlying disease process.
Like many neurodegenerative diseases, chronic inflammation in the brain—or neuroinflammation—is now recognized as a major contributor to Parkinson’s progression. This inflammation damages neurons and accelerates dopamine depletion.
Umbilical cord stem cells, particularly mesenchymal stem cells (MSCs), show significant promise in addressing Parkinson’s disease at its root. These cells are:
Since 2010, stem cell therapy has been studied in patients with Parkinson’s disease, and several clinical trials have demonstrated meaningful improvements.
Request a consultation to discuss any questions for you or for you child.
For patients with Parkinson’s, we need more than symptom relief—we need solutions that get to the root of the disease. Stem cell therapy offers a new direction that addresses both inflammation and regeneration.